Manufacturing, Packaging & Detailing Market Research Reports & Industry Analysis
Current Good Manufacturing Practices (cGMPs) refers to the regulations enforced by the FDA. The cGMPs provide for systems that assure proper design, monitoring, and control of manufacturing processes and facilities.
Adherence to the cGMP regulations assures the identity, strength, quality, and purity of drug products by requiring that manufacturers of medications adequately control manufacturing operations. This includes establishing strong quality management systems, obtaining appropriate quality raw materials, establishing robust operating procedures, detecting and investigating product quality deviations, and maintaining reliable testing laboratories. This formal system of controls at a pharmaceutical company, if adequately put into practice, helps to prevent instances of contamination, mix-ups, deviations, failures, and errors. This assures that drug products meet their quality standards.
The cGMP requirements were established to be flexible in order to allow each manufacturer to decide individually how to best implement the necessary controls by using scientifically sound design, processing methods, and testing procedures. The flexibility in these regulations allows companies to use modern technologies and innovative approaches to achieve higher quality through continual improvement.
- Use of RFID in serialized unique packaging numbering to authenticate and check for recall/expiry status.
- Use of X-ray and metal detection systems to detect glass, stone, bone, rubber and other contaminants
- Use of checkweighers and sorters
- Use of baggers capable of handling, opening and sealing bags manufactured from specialist sterile films and papers.
- Use of quality control labeling systems
It is important to note that cGMPs are minimum requirements. Many pharmaceutical manufacturers are already implementing comprehensive, modern quality systems and risk management approaches that exceed these minimum standards. This is important because a consumer cannot detect through smell, touch, or sight if a drug product is safe or if it will work.
Manufacturing, Packaging & Detailing Industry Research & Market Reports
-
The 2026-2031 World Outlook for Bench-Top Lyophilizers
... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More
-
The 2026-2031 World Outlook for Antivenom Serum
... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More
-
The 2026-2031 World Outlook for Anti-Rejection Drugs and Immunosuppressants for Liver Diseases Treatments
... (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country ... Read More
-
The 2026-2031 World Outlook for Anti-Infectives
... millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project ... Read More
-
The 2026-2031 World Outlook for Anti-Epileptic Drugs
... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More
-
The 2026-2031 World Outlook for Enteral Antibacterial Drugs
... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More
-
The 2026-2031 World Outlook for Farnesene
... millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project ... Read More
-
The 2026-2031 World Outlook for Ferric Citrate
... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More
-
The 2026-2031 World Outlook for Drug Eluting Balloons (DEB)
... in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric ... Read More
-
The 2026-2031 World Outlook for Drug Eluting Balloons (DEBs)
... in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric ... Read More
-
Healthcare Data Monetization Market by Type (Direct, Indirect), Deployment (On-premise, Cloud), End User (Pharmaceutical & Biotechnology Companies, Healthcare Payers, Healthcare Providers, Medical Technology Companies) & Region- Global Forecast to 2030
... is mainly driven by the increasing volume of medical imaging data, the shift towards enterprise-wide interoperability, and the rising demand for centralized, vendor-neutral platforms that streamline imaging workflows. Additionally, healthcare digitization initiatives and regulatory support ... Read More
-
High Potency Active Pharmaceutical Ingredients Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... According to a new analysis by Fairfield Market Research, the HPAPI market is estimated to be valued at US$ 230 million in 2025 and is projected to reach US$ 410 million by 2032, growing at ... Read More
-
Global Gastrointestinal Diseases Therapeutics Market 2025-2029
... diseases therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
Biological Product Manufacturing - 2025 U.S. Market Research Report with Updated Recession Risk, Forecasts, & Tariff Analysis (Updated with China tariffs at 30%)
... report is packed with insightful data sets and forecasts to give you a comprehensive understanding of the industry including historical and forecasted industry size, growth, tariff impact analysis, product line breakdown, profitability, financial ratios, 31 ... Read More
-
Medical Plant & Herb Processing - 2025 U.S. Market Research Report with Updated Recession Risk, Forecasts, & Tariff Analysis (Updated with China tariffs at 30%)
... Kentley Insights report is packed with insightful data sets and forecasts to give you a comprehensive understanding of the industry including historical and forecasted industry size, growth, tariff impact analysis, product line breakdown, profitability, financial ... Read More
-
Medicine Manufacturing - 2025 U.S. Market Research Report with Updated Recession Risk, Forecasts, & Tariff Analysis (Updated with China tariffs at 30%)
... is packed with insightful data sets and forecasts to give you a comprehensive understanding of the industry including historical and forecasted industry size, growth, tariff impact analysis, product line breakdown, profitability, financial ratios, 31 balance ... Read More
-
Industrial Evaporators Market by Construction Type (Shell & Tube Evaporators, Plate Evaporators), Functionality (Falling Film, Rising Film), End-use Industry (Food & Beverage, Pharmaceutical, Automotive), and Region - Global Forecast to 2030
... thermal separation processes is evident across multiple industries, including food & beverage, pharmaceuticals, chemicals, and wastewater treatment. The rise in industrialization, coupled with the imperative for effective concentration, purification, and solvent recovery methods, is driving ... Read More
-
Pharmaceutical Manufacturing - 2025 U.S. Market Research Report with Updated Recession Risk, Forecasts, & Tariff Analysis (Updated with China tariffs at 30%)
... is packed with insightful data sets and forecasts to give you a comprehensive understanding of the industry including historical and forecasted industry size, growth, tariff impact analysis, product line breakdown, profitability, financial ratios, 31 balance ... Read More
-
Global Pharmaceutical Visual Inspection Systems Market - 2025-2033
... the forecast period 2025-2033. Pharmaceutical Visual Inspection Systems Market The pharmaceutical visual inspection systems market is poised for continued growth, with advancements in AI and machine learning leading to more sophisticated and efficient inspection solutions. ... Read More
-
Global Active and Intelligent Packaging in Pharmaceutical Market 2025-2029
... period. The report on the active and intelligent packaging in pharmaceutical market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The ... Read More
-
Cyclic Olefin Polymer Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2025-2034
... driven by rising demand for high-performance, transparent materials in the medical, pharmaceutical, and optical sectors. Cyclic olefin polymers (COPs) are gaining momentum due to their excellent optical clarity, moisture barrier properties, and biocompatibility, which make ... Read More
-
Pharmaceutical Product Manufacturing in Australia - Industry Market Research Report
... has also benefited several participants. However, ongoing challenges including a changing regulatory and risk environment and reform-driven pricing pressures have constrained the industry's growth. Ongoing PBS reforms have heavily influenced manufacturers over the period, as ... Read More
-
Alopecia Drugs
... CAGR of 5.5% over the analysis period 2024-2030. Topical, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$8.4 Billion by the end of the analysis period. ... Read More
-
Pharmaceutical Contract Manufacturing
... at a CAGR of 5.2% over the analysis period 2024-2030. Pharmaceutical, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$93.8 Billion by the end of the ... Read More
-
Sustainable Pharmaceutical Packaging
... at a CAGR of 15.3% over the analysis period 2024-2030. Plastics, one of the segments analyzed in the report, is expected to record a 17.4% CAGR and reach US$127.3 Billion by the end of the ... Read More
Research Assistance
